Search patents:
Method of monitoring manufacturing apparatus
Method of monitoring manufacturing apparatus
Filed: March 16th, 2001 [Pending]
Patent Application Number: 9809085
... 12 El 2000/5/3 04: 04 A 3 El 2000/5/3 04: 04 B 12 El 2000/5/3 04: 05 A 2 El 2000/5/3 04: 05 B 12 • E-2 2000/4/30 14 :12 A 0 E-2 2000/4/30 14 :12 B 3 E-2 ...
Method for producing 1-substituted-1,2,3-triazole derivative
Method for producing 1-substituted-1,2,3-triazole derivative
Filed: April 19th, 2002 [Granted]
Patent Number: 6743924
89 90 -continued (E)-3-(4-(Trifluoromethyl)phenyl)-2-propenamide (4.00 g, ... mmol) was added and the mixture was reffuxed under 30 stirring for 2 hours.
Drug delivery system comprising a tetrahydroxilated estrogen for use in ...
Drug delivery system comprising a tetrahydroxilated estrogen for use in ...
Filed: May 25th, 2004 [Pending]
Patent Application Number: 10478365
[0108] Twice daily po doses of 30 fig E2/kg for 4 days were ineffective in ... are indistinguishable from SHBG in human serum (Awakumov GV et al., 2000.
Azo dyes and azo-metal complexes for atomic force microscope lithography
Azo dyes and azo-metal complexes for atomic force microscope lithography
Filed: August 8th, 2002 [Granted]
Patent Number: 6716563
The prepared resist composition is spun at 2000-3000 rpm for 20^-0 s using a spin ... 1H) 40 PREPARING EXAMPLE 2 4-((E)-2-Amino-6-methoxybenzothiazole)-azo ...
HCV neutralizing epitopes
HCV neutralizing epitopes
Filed: October 24th, 2008 [Pending]
Patent Application Number: 12290017
(i) To study the relative reactivity of Fabs to GST-E1E2 and E2, soluble Fabs were ... Sigma) for 30 min before the addition of soluble Fabs (2 |xg/mL).
Small-molecule nucleotide aptamer for hepatitis C virus, preparation method ...
Small-molecule nucleotide aptamer for hepatitis C virus, preparation method ...
Filed: October 20th, 2009 [Pending]
Patent Application Number: 12581930
... for 15 min and in an ice bath for 5 min respectively, mixing with 10° CT26- HCV-E2 in a 1>< screening buffer, oscillating at 37° C. for 30 min, 2000 rpm ...
Cis/trans isomerization of 6-(substituted-aryl-ethenyl)-3,4,5,6-tetrahydro-4 ...
Cis/trans isomerization of 6-(substituted-aryl-ethenyl)-3,4,5,6-tetrahydro-4 ...
Filed: September 2nd, 1980 [Granted]
Assignee: Merck Co Inc
Patent Number: 4308378
The result- dose for adults is. preferably between 200 and 2000 mg ing ... at 60 ° for 30 minutes and .„ ' n r. e treated with benzyl bromide (10.6 g, 62.
Immunogenic composition of hepatitis C and methods of use thereof
Immunogenic composition of hepatitis C and methods of use thereof
Filed: September 13th, 2001 [Pending]
Patent Application Number: 9952572
4, the purified recombinant E2 fraction does not contain multimeric ... (2000) have determined whether their human monoclonal antibodies block the binding ...